Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.15 trillion and total revenue of $110.02 billion.
Market Cap
1.15T
Revenue
110.02B
Profits
-39.91B
PE Ratio
n/a
Profit Margin
-36.28%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.36B | -0.99% | 966,767 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.74B | -0.95% | 603,195 | 14.34B |
| 3 | ARGX | argenx SE | 49.41B | 0.45% | 227,035 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.92B | 0.97% | 1,093,318 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.15B | -0.63% | 201,606 | 5.34B |
| 6 | RPRX | Royalty Pharma plc | 29.43B | 0.55% | 4,113,288 | 2.38B |
| 7 | INSM | Insmed Incorporated | 29.35B | 0.60% | 1,116,502 | 606.42M |
| 8 | RVMD | Revolution Medicines, Inc. | 27.69B | -2.68% | 4,833,043 | - |
| 9 | BNTX | BioNTech SE | 25.81B | -3.22% | 823,563 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.93B | 1.61% | 5,007,331 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 19.31B | -4.00% | 6,074,576 | 1.94B |
| 12 | INCY | Incyte Corporation | 19.05B | 1.13% | 2,148,449 | 5.14B |
| 13 | SMMT | Summit Therapeutics Inc. | 17.17B | 0.18% | 3,702,478 | - |
| 14 | GMAB | Genmab A/S | 16.46B | -0.86% | 870,721 | 3.72B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.45B | 1.69% | 3,011,898 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.00B | -1.14% | 714,635 | 845.52M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.39B | 2.39% | 1,310,557 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 11.93B | -1.42% | 2,311,575 | 943.71M |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.93B | 1.50% | 216,020 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.34B | -0.65% | 2,103,538 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.40B | 1.18% | 1,461,756 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.31B | -0.42% | 1,420,328 | 1.09B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.59B | 0.77% | 887,192 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.22B | -4.01% | 358,563 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.98B | -2.32% | 787,578 | 5.37M |
| 26 | TECH | Bio-Techne Corporation | 8.62B | 1.70% | 1,454,192 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.59B | 0.39% | 1,006,996 | - |
| 28 | NUVL | Nuvalent, Inc. | 8.18B | -0.44% | 491,390 | - |
| 29 | KRYS | Krystal Biotech, Inc. | 8.03B | 0.08% | 242,385 | 389.13M |
| 30 | CYTK | Cytokinetics, Incorporated | 7.65B | -5.70% | 2,259,320 | 88.04M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.64B | -1.33% | 1,321,764 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.53B | -2.02% | 11,101,576 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.08B | 2.08% | 513,559 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.75B | 0.03% | 16,117,821 | 22.29M |
| 35 | BLTE | Belite Bio, Inc | 6.41B | 1.12% | 70,064 | - |
| 36 | APGE | Apogee Therapeutics, Inc. | 6.39B | 1.03% | 970,519 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.29B | -1.49% | 994,653 | 46.02M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.20B | 3.20% | 686,941 | - |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.11% | 4,243,476 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.11B | 0.10% | 1,642,649 | 15.00M |
| 41 | CELC | Celcuity Inc. | 6.07B | 3.84% | 995,381 | - |
| 42 | ERAS | Erasca, Inc. | 5.95B | -10.89% | 22,571,520 | - |
| 43 | COGT | Cogent Biosciences, Inc. | 5.90B | -0.56% | 1,038,815 | - |
| 44 | IMVT | Immunovant, Inc. | 5.83B | 0.14% | 934,890 | - |
| 45 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.82B | -0.58% | 355,757 | 189.76M |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.74B | 1.45% | 1,058,261 | 1.73B |
| 47 | CGON | CG Oncology, Inc. | 5.64B | -2.71% | 757,935 | 4.04M |
| 48 | MIRM | Mirum Pharmaceuticals, Inc. | 5.64B | 1.08% | 430,349 | 521.31M |
| 49 | CAI | Caris Life Sciences, Inc. | 5.63B | -1.34% | 1,286,979 | 812.03M |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.32B | -0.41% | 1,268,214 | - |
| 51 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | 0.02% | 2,747,529 | 1.00B |
| 52 | TGTX | TG Therapeutics, Inc. | 5.22B | -3.39% | 1,655,275 | 616.29M |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 5.18B | -1.77% | 693,846 | 7.50M |
| 54 | CORT | Corcept Therapeutics Incorporated | 4.96B | 0.35% | 646,656 | 761.41M |
| 55 | CRSP | CRISPR Therapeutics AG | 4.91B | 4.51% | 2,925,140 | 3.51M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 4.85B | 4.55% | 280,972 | 268.09M |
| 57 | DNTH | Dianthus Therapeutics, Inc. | 4.75B | -0.26% | 599,201 | 2.04M |
| 58 | FOLD | Amicus Therapeutics, Inc. | 4.55B | 0.21% | - | 634.21M |
| 59 | LEGN | Legend Biotech Corporation | 4.37B | -1.05% | 1,491,421 | 1.03B |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.04B | 0.76% | 906,989 | 7.70M |
| 61 | ORKA | Oruka Therapeutics, Inc. | 3.83B | 10.66% | 6,900,048 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.82B | 0.72% | 1,532,085 | - |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 1.55% | 1,075,529 | 1.07B |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.80B | 2.17% | 2,712,987 | 62.38M |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.77B | 0.77% | 1,011,274 | 490.73M |
| 66 | MANE | Veradermics, Incorporated | 3.74B | 47.55% | 3,360,484 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.58B | -1.52% | 102,252 | 803.79M |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.57B | 6.94% | 9,324,337 | 588.99M |
| 69 | NAMS | NewAmsterdam Pharma Company N.V. | 3.50B | 2.46% | 1,276,588 | 22.50M |
| 70 | EWTX | Edgewise Therapeutics, Inc. | 3.29B | -2.98% | 1,054,759 | - |
| 71 | GPCR | Structure Therapeutics Inc. | 3.21B | -0.35% | 576,417 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 3.16B | 0.35% | 1,030,282 | - |
| 73 | ALMS | Alumis Inc. | 3.15B | -0.72% | 1,057,692 | 24.05M |
| 74 | RCUS | Arcus Biosciences, Inc. | 3.13B | -2.16% | 1,141,548 | 247.00M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.98B | -1.20% | 1,718,525 | - |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 2.93B | 0.69% | 821,570 | 376.07M |
| 77 | NKTR | Nektar Therapeutics | 2.93B | -5.39% | 1,606,376 | 55.23M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.92B | 7.58% | 3,150,455 | 139.74M |
| 79 | KLRA | Kailera Therapeutics, Inc. | 2.91B | 4.63% | 1,070,280 | - |
| 80 | RLAY | Relay Therapeutics, Inc. | 2.83B | -1.19% | 4,108,537 | 15.36M |
| 81 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.06% | 1,195,582 | 190.41M |
| 82 | KOD | Kodiak Sciences Inc. | 2.72B | -1.63% | 520,087 | - |
| 83 | ELVN | Enliven Therapeutics, Inc. | 2.69B | 1.47% | 629,399 | - |
| 84 | VERA | Vera Therapeutics, Inc. | 2.67B | -1.09% | 756,283 | - |
| 85 | IMNM | Immunome, Inc. | 2.66B | -0.30% | 1,109,936 | 6.94M |
| 86 | CLDX | Celldex Therapeutics, Inc. | 2.64B | 1.11% | 851,714 | 1.55M |
| 87 | IRON | Disc Medicine, Inc. | 2.63B | - | 238,694 | - |
| 88 | TARS | Tarsus Pharmaceuticals, Inc. | 2.59B | -0.85% | 563,811 | 451.36M |
| 89 | IDYA | IDEAYA Biosciences, Inc. | 2.59B | -4.07% | 961,426 | 218.71M |
| 90 | ADMA | ADMA Biologics, Inc. | 2.54B | -2.93% | 5,551,317 | 510.17M |
| 91 | ZLAB | Zai Lab Limited | 2.46B | -3.91% | 252,396 | 460.16M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.35B | -0.46% | 1,810,332 | 673.00M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.23B | -1.89% | 836,919 | - |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | 3.35% | 3,139,344 | 2.20B |
| 95 | TYRA | Tyra Biosciences, Inc. | 2.20B | -1.78% | 882,816 | - |
| 96 | ADPT | Adaptive Biotechnologies Corporation | 2.19B | 0.50% | 1,063,363 | 276.98M |
| 97 | AAPG | Ascentage Pharma Group International | 2.17B | -2.42% | 1,807 | 82.08M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 2.44% | 1,138,670 | 283.06M |
| 99 | ZYME | Zymeworks Inc. | 2.11B | 1.64% | 950,209 | 105.97M |
| 100 | DFTX | Definium Therapeutics, Inc. | 2.09B | -6.67% | 1,999,856 | - |
| 101 | OCUL | Ocular Therapeutix, Inc. | 2.07B | 0.32% | 2,548,486 | 51.95M |
| 102 | CAPR | Capricor Therapeutics, Inc. | 2.03B | -0.48% | 993,537 | 11.13M |
| 103 | TRVI | Trevi Therapeutics, Inc. | 2.00B | -0.97% | 1,274,122 | - |
| 104 | STOK | Stoke Therapeutics, Inc. | 1.99B | -0.94% | 276,034 | 184.42M |
| 105 | MESO | Mesoblast Limited | 1.99B | -1.16% | 105,087 | 65.38M |
| 106 | INBX | Inhibrx Biosciences, Inc. | 1.92B | 1.85% | 780,705 | 1.30M |
| 107 | ANAB | AnaptysBio, Inc. | 1.91B | 13.09% | 1,122,643 | 234.60M |
| 108 | GLPG | Galapagos NV | 1.89B | -0.17% | 141,423 | 1.31B |
| 109 | VCEL | Vericel Corporation | 1.88B | 3.76% | 656,863 | 276.26M |
| 110 | PHVS | Pharvaris N.V. | 1.88B | 0.28% | 172,306 | - |
| 111 | TSHA | Taysha Gene Therapies, Inc. | 1.86B | 0.94% | 1,988,094 | 9.77M |
| 112 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | -1.82% | 1,316,485 | 172.35M |
| 113 | PVLA | Palvella Therapeutics, Inc. | 1.84B | 4.09% | 215,668 | - |
| 114 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | -0.85% | 10,903,150 | 74.68M |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.80B | 0.81% | 831,910 | 868.45M |
| 116 | SION | Sionna Therapeutics, Inc. | 1.76B | 2.89% | 623,674 | - |
| 117 | INVA | Innoviva, Inc. | 1.73B | -0.89% | 541,113 | 411.33M |
| 118 | VIR | Vir Biotechnology, Inc. | 1.72B | 2.60% | 1,847,941 | 68.56M |
| 119 | NRIX | Nurix Therapeutics, Inc. | 1.71B | -1.14% | 615,583 | 71.78M |
| 120 | RAPP | Rapport Therapeutics, Inc. | 1.69B | -3.17% | 246,807 | - |
| 121 | NBTX | Nanobiotix S.A. | 1.61B | -2.23% | 41,832 | 38.27M |
| 122 | OCS | Oculis Holding AG | 1.60B | 2.53% | 616,294 | 1.51M |
| 123 | GENB | Generate Biomedicines, Inc. | 1.59B | -2.73% | 258,443 | 31.89M |
| 124 | NUVB | Nuvation Bio Inc. | 1.59B | -6.75% | 6,550,240 | 62.90M |
| 125 | ATAI | AtaiBeckley Inc. | 1.58B | -6.26% | 5,160,837 | 4.09M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.54B | -2.53% | 598,271 | 123.67M |
| 127 | NTLA | Intellia Therapeutics, Inc. | 1.54B | -4.33% | 27,133,234 | 67.67M |
| 128 | DMRA | Damora Therapeutics, Inc. | 1.54B | 3.03% | 267,334 | - |
| 129 | IMTX | Immatics N.V. | 1.52B | - | 358,329 | 56.67M |
| 130 | MBX | MBX Biosciences, Inc. | 1.52B | 0.03% | 385,657 | - |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.47B | -0.77% | 292,604 | - |
| 132 | ARDX | Ardelyx, Inc. | 1.47B | 0.67% | 2,679,347 | 407.32M |
| 133 | MAZE | Maze Therapeutics, Inc. | 1.46B | 2.56% | 588,028 | 2.50M |
| 134 | IMCR | Immunocore Holdings plc | 1.45B | -2.53% | 351,661 | 400.02M |
| 135 | BHVN | Biohaven Ltd. | 1.44B | -2.94% | 1,372,713 | - |
| 136 | AGIO | Agios Pharmaceuticals, Inc. | 1.43B | -3.52% | 1,070,584 | 54.03M |
| 137 | IOVA | Iovance Biotherapeutics, Inc. | 1.41B | -0.29% | 10,318,455 | 263.50M |
| 138 | PGEN | Precigen, Inc. | 1.40B | -4.12% | 2,801,889 | 9.68M |
| 139 | VRDN | Viridian Therapeutics, Inc. | 1.39B | -1.68% | 2,320,075 | 70.85M |
| 140 | MPLT | MapLight Therapeutics, Inc. | 1.35B | 2.96% | 494,117 | - |
| 141 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -0.30% | 683,669 | - |
| 142 | CRVS | Corvus Pharmaceuticals, Inc. | 1.34B | -1.00% | 938,548 | - |
| 143 | WVE | Wave Life Sciences Ltd. | 1.33B | -3.34% | 3,826,361 | 42.73M |
| 144 | OLMA | Olema Pharmaceuticals, Inc. | 1.33B | -1.55% | 720,477 | - |
| 145 | NVAX | Novavax, Inc. | 1.31B | -1.82% | 2,654,830 | 1.12B |
| 146 | JBIO | Jade Biosciences, Inc. | 1.31B | 6.65% | 915,752 | - |
| 147 | SVRA | Savara Inc. | 1.31B | 0.78% | 1,393,932 | - |
| 148 | ABCL | AbCellera Biologics Inc. | 1.26B | 0.24% | 11,892,487 | 75.13M |
| 149 | DBVT | DBV Technologies S.A. | 1.22B | 2.98% | 159,946 | 5.64M |
| 150 | GHRS | GH Research PLC | 1.22B | -3.23% | 256,185 | - |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.21B | -1.92% | 480,127 | - |
| 152 | PHAR | Pharming Group N.V. | 1.18B | - | 10,617 | 376.13M |
| 153 | URGN | UroGen Pharma Ltd. | 1.16B | -1.41% | 442,245 | 109.79M |
| 154 | EYPT | EyePoint, Inc. | 1.13B | -1.23% | 692,123 | 31.37M |
| 155 | QURE | uniQure N.V. | 1.13B | -0.72% | 1,295,460 | 16.10M |
| 156 | SEPN | Septerna, Inc. | 1.13B | 1.60% | 370,790 | 45.95M |
| 157 | AKTS | Aktis Oncology, Inc. | 1.11B | -5.50% | 218,672 | 6.50M |
| 158 | ZBIO | Zenas BioPharma, Inc. | 1.11B | 2.20% | 344,439 | 10.00M |
| 159 | OMER | Omeros Corporation | 1.06B | 8.94% | 1,913,046 | - |
| 160 | IVA | Inventiva S.A. | 1.06B | -0.39% | 186,572 | 7.94M |
| 161 | XERS | Xeris Biopharma Holdings, Inc. | 1.06B | 1.16% | 958,141 | 291.85M |
| 162 | ORIC | ORIC Pharmaceuticals, Inc. | 1.02B | -0.49% | 1,377,455 | - |
| 163 | ANNX | Annexon, Inc. | 991.29M | 3.74% | 3,090,358 | - |
| 164 | FTRE | Fortrea Holdings Inc. | 991.10M | 8.16% | 1,798,386 | 2.72B |
| 165 | KALV | KalVista Pharmaceuticals, Inc. | 981.42M | -2.39% | 1,072,192 | 73.62M |
| 166 | GERN | Geron Corporation | 980.58M | 2.00% | 12,325,187 | 183.88M |
| 167 | XNCR | Xencor, Inc. | 960.74M | 0.92% | 1,106,745 | 125.58M |
| 168 | MRVI | Maravai LifeSciences Holdings, Inc. | 946.01M | 3.66% | 1,598,164 | 185.74M |
| 169 | CTMX | CytomX Therapeutics, Inc. | 933.91M | -2.50% | 2,489,294 | 76.20M |
| 170 | JANX | Janux Therapeutics, Inc. | 926.47M | 1.47% | 914,028 | 10.00M |
| 171 | PHAT | Phathom Pharmaceuticals, Inc. | 920.59M | -0.94% | 1,220,644 | 175.11M |
| 172 | LBRX | LB Pharmaceuticals Inc | 912.17M | 3.51% | 242,203 | - |
| 173 | EVMN | Evommune, Inc. | 900.46M | -1.50% | 218,294 | 13.00M |
| 174 | SANA | Sana Biotechnology, Inc. | 894.46M | -0.91% | 2,871,106 | - |
| 175 | SLS | SELLAS Life Sciences Group, Inc. | 876.36M | 9.42% | 6,524,626 | - |
| 176 | DRUG | Bright Minds Biosciences Inc. | 873.45M | 1.21% | 217,881 | - |
| 177 | TBPH | Theravance Biopharma, Inc. | 865.60M | 2.13% | 255,575 | 107.46M |
| 178 | ANRO | Alto Neuroscience, Inc. | 850.73M | -1.02% | 185,315 | - |
| 179 | MGTX | MeiraGTx Holdings plc | 845.05M | -1.08% | 665,899 | 81.39M |
| 180 | ABUS | Arbutus Biopharma Corporation | 842.90M | 1.90% | 5,061,266 | 14.08M |
| 181 | CBIO | Crescent Biopharma, Inc. | 835.71M | 1.41% | 145,665 | 10.84M |
| 182 | MNKD | MannKind Corporation | 812.13M | -2.59% | 3,927,918 | 348.97M |
| 183 | KURA | Kura Oncology, Inc. | 805.08M | -2.05% | 872,760 | 67.48M |
| 184 | CGEM | Cullinan Therapeutics, Inc. | 801.97M | 0.23% | 600,058 | - |
| 185 | SGP | SpyGlass Pharma, Inc. | 790.54M | - | 111,080 | - |
| 186 | DSGN | Design Therapeutics, Inc. | 790.02M | 2.23% | 318,418 | - |
| 187 | SPRY | ARS Pharmaceuticals, Inc. | 789.41M | -4.10% | 1,980,056 | 84.28M |
| 188 | ALLO | Allogene Therapeutics, Inc. | 773.95M | -2.60% | 6,539,784 | 22.00K |
| 189 | VOR | Vor Biopharma Inc. | 765.10M | 2.24% | 1,089,313 | - |
| 190 | TENX | Tenax Therapeutics, Inc. | 760.04M | 5.66% | 1,977,754 | - |
| 191 | ABSI | Absci Corporation | 742.15M | 23.10% | 11,466,010 | 2.80M |
| 192 | SLDB | Solid Biosciences Inc. | 737.96M | -5.30% | 745,600 | - |
| 193 | RLMD | Relmada Therapeutics, Inc. | 737.36M | -2.50% | 1,416,573 | - |
| 194 | LXRX | Lexicon Pharmaceuticals, Inc. | 716.02M | 0.60% | 1,920,472 | 49.80M |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 703.49M | 0.11% | 525,363 | - |
| 196 | GYRE | Gyre Therapeutics, Inc. | 696.73M | 2.82% | 22,740 | 116.59M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 696.16M | -2.22% | 403,221 | - |
| 198 | ARVN | Arvinas, Inc. | 658.16M | -1.44% | 425,306 | 262.60M |
| 199 | FBRX | Forte Biosciences, Inc. | 654.55M | -2.59% | 182,589 | - |
| 200 | PRME | Prime Medicine, Inc. | 649.88M | -0.81% | 1,630,484 | 4.63M |
| 201 | TRAX | First Tracks Biotherapeutics, Inc. | 628.95M | -0.33% | 425,224 | - |
| 202 | CRMD | CorMedix Inc. | 613.31M | 5.39% | 1,689,046 | 311.71M |
| 203 | ACRS | Aclaris Therapeutics, Inc. | 612.97M | 2.56% | 814,083 | 7.83M |
| 204 | STTK | Shattuck Labs, Inc. | 583.49M | -0.26% | 421,559 | 1.00M |
| 205 | PRTA | Prothena Corporation plc | 580.86M | 0.37% | 314,337 | 9.68M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 579.92M | -2.68% | 764,847 | 106.47M |
| 207 | OCGN | Ocugen, Inc. | 575.48M | 2.41% | 4,523,830 | 4.41M |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 563.83M | 0.73% | 200,279 | 294.28M |
| 209 | PROK | ProKidney Corp. | 561.65M | -4.12% | 514,328 | 893.00K |
| 210 | STRO | Sutro Biopharma, Inc. | 556.49M | 0.78% | 190,697 | 102.48M |
| 211 | AGMB | AgomAb Therapeutics NV | 551.70M | 2.44% | 197,927 | - |
| 212 | KYTX | Kyverna Therapeutics, Inc. | 544.17M | -0.77% | 1,111,328 | - |
| 213 | ALT | Altimmune, Inc. | 543.76M | -1.75% | 5,891,799 | 41.00K |
| 214 | TECX | Tectonic Therapeutic, Inc. | 539.83M | 0.74% | 154,931 | - |
| 215 | LYEL | Lyell Immunopharma, Inc. | 531.19M | 1.61% | 65,699 | 36.00K |
| 216 | ANL | Adlai Nortye Ltd. | 530.00M | -10.47% | 556,742 | 5.00M |
| 217 | FULC | Fulcrum Therapeutics, Inc. | 514.15M | -1.53% | 1,145,267 | 80.00M |
| 218 | ZURA | Zura Bio Limited | 513.30M | 0.56% | 538,453 | - |
| 219 | UPB | Upstream Bio, Inc. | 505.56M | -0.11% | 664,688 | 2.85M |
| 220 | IMMX | Immix Biopharma, Inc. | 505.21M | -3.25% | 462,194 | - |
| 221 | XOMA | XOMA Royalty Corporation | 500.10M | 10.74% | 3,180,334 | 52.15M |
| 222 | MDXG | MiMedx Group, Inc. | 496.21M | -2.62% | 1,335,607 | 418.63M |
| 223 | VSTM | Verastem, Inc. | 486.65M | -6.26% | 1,401,510 | 30.91M |
| 224 | VALN | Valneva SE | 485.14M | -0.18% | 20,935 | 205.07M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 484.25M | 4.75% | 159,691 | - |
| 226 | FDMT | 4D Molecular Therapeutics, Inc. | 482.44M | 0.53% | 628,798 | 85.21M |
| 227 | ENGN | enGene Therapeutics Inc. | 482.32M | -9.89% | 846,041 | - |
| 228 | ADCT | ADC Therapeutics SA | 478.23M | -4.57% | 770,839 | 81.36M |
| 229 | EIKN | Eikon Therapeutics, Inc. | 473.17M | -9.52% | 262,958 | - |
| 230 | TRDA | Entrada Therapeutics, Inc. | 466.56M | 2.61% | 140,337 | 25.42M |
| 231 | OVID | Ovid Therapeutics Inc. | 465.47M | 3.46% | 1,275,265 | 7.25M |
| 232 | LRMR | Larimar Therapeutics, Inc. | 461.24M | -2.20% | 1,395,996 | - |
| 233 | CADL | Candel Therapeutics, Inc. | 460.72M | -3.23% | 1,390,805 | - |
| 234 | DNA | Ginkgo Bioworks Holdings, Inc. | 455.18M | -0.64% | 811,396 | 170.16M |
| 235 | PRLD | Prelude Therapeutics Incorporated | 454.50M | -3.83% | 586,453 | 12.14M |
| 236 | CLYM | Climb Bio, Inc. | 453.80M | 3.94% | 433,684 | - |
| 237 | AURA | Aura Biosciences, Inc. | 446.83M | -4.26% | 185,114 | - |
| 238 | EPRX | Eupraxia Pharmaceuticals Inc. | 445.74M | 0.70% | 184,285 | - |
| 239 | RGNX | REGENXBIO Inc. | 444.94M | -1.60% | 669,718 | 170.44M |
| 240 | ASMB | Assembly Biosciences, Inc. | 436.54M | -1.26% | 49,251 | 72.30M |
| 241 | BNTC | Benitec Biopharma Inc. | 431.95M | 1.94% | 136,263 | - |
| 242 | AVIR | Atea Pharmaceuticals, Inc. | 427.04M | -2.01% | 187,768 | - |
| 243 | NGNE | Neurogene Inc. | 422.41M | 0.07% | 127,056 | 925.00K |
| 244 | LXEO | Lexeo Therapeutics, Inc. | 416.74M | -3.85% | 728,501 | - |
| 245 | PRTC | PureTech Health plc | 412.93M | 2.36% | 4,841 | 6.39M |
| 246 | IVVD | Invivyd, Inc. | 412.89M | - | 1,167,191 | 53.43M |
| 247 | NMRA | Neumora Therapeutics, Inc. | 405.57M | -1.33% | 952,642 | - |
| 248 | IPSC | Century Therapeutics, Inc. | 405.13M | 1.35% | 568,583 | 109.16M |
| 249 | ARMP | Armata Pharmaceuticals, Inc. | 402.96M | -14.86% | 192,773 | 4.90M |
| 250 | VNDA | Vanda Pharmaceuticals Inc. | 401.34M | -1.45% | 1,426,527 | 216.11M |
| 251 | NAGE | Niagen Bioscience, Inc. | 398.03M | 0.61% | 697,289 | 129.42M |
| 252 | LCTX | Lineage Cell Therapeutics, Inc. | 386.09M | - | 642,162 | 14.56M |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 385.38M | -0.41% | 92,383 | 66.98M |
| 254 | AVTX | Avalo Therapeutics, Inc. | 385.22M | 3.59% | 679,966 | 59.00K |
| 255 | YDES | YD Bio Limited | 383.95M | - | 6,428 | 510.36K |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 382.77M | 2.43% | 369,554 | 35.11M |
| 257 | PBYI | Puma Biotechnology, Inc. | 382.08M | -0.40% | 193,079 | 228.37M |
| 258 | RCKT | Rocket Pharmaceuticals, Inc. | 380.84M | -0.85% | 1,843,338 | - |
| 259 | AUTL | Autolus Therapeutics plc | 377.92M | -1.39% | 659,852 | 75.39M |
| 260 | IMRX | Immuneering Corporation | 372.66M | -4.64% | 761,294 | - |
| 261 | SLN | Silence Therapeutics plc | 369.37M | 1.56% | 359,150 | 559.00K |
| 262 | IRD | Opus Genetics, Inc. | 365.58M | -2.10% | 737,664 | 14.20M |
| 263 | VTVT | vTv Therapeutics Inc. | 364.84M | -10.26% | 104,637 | 17.00K |
| 264 | MNPR | Monopar Therapeutics Inc. | 361.51M | 1.54% | 67,253 | - |
| 265 | SRZN | Surrozen, Inc. | 344.03M | 6.43% | 112,070 | 3.48M |
| 266 | RZLT | Rezolute, Inc. | 343.82M | 6.77% | 3,880,169 | - |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 340.54M | -0.16% | 96,819 | - |
| 268 | BCYC | Bicycle Therapeutics plc | 332.50M | -1.45% | 273,892 | 72.59M |
| 269 | GLSI | Greenwich LifeSciences, Inc. | 332.37M | -0.91% | 63,136 | - |
| 270 | PALI | Palisade Bio, Inc. | 328.15M | -5.77% | 3,436,258 | - |
| 271 | NAUT | Nautilus Biotechnology, Inc. | 325.27M | -1.91% | 322,577 | - |
| 272 | CABA | Cabaletta Bio, Inc. | 323.95M | -1.36% | 1,177,487 | - |
| 273 | CMPX | Compass Therapeutics, Inc. | 322.36M | -64.41% | 158,499,681 | 850.00K |
| 274 | IKT | Inhibikase Therapeutics, Inc. | 322.15M | 0.53% | 690,403 | 1.00 |
| 275 | NGEN | NervGen Pharma Corp. | 311.58M | -1.79% | 366,816 | - |
| 276 | LENZ | LENZ Therapeutics, Inc. | 306.02M | 4.05% | 816,015 | 19.09M |
| 277 | FHTX | Foghorn Therapeutics Inc. | 305.83M | -1.88% | 143,651 | 30.91M |
| 278 | AVXL | Anavex Life Sciences Corp. | 304.89M | -1.50% | 739,583 | - |
| 279 | ABEO | Abeona Therapeutics Inc. | 303.75M | -0.93% | 598,106 | 5.82M |
| 280 | ZNTL | Zentalis Pharmaceuticals, Inc. | 301.46M | 6.78% | 1,427,495 | 26.87M |
| 281 | CLLS | Cellectis S.A. | 295.68M | 3.08% | 19,431 | 79.59M |
| 282 | CHRS | Coherus Oncology, Inc. | 283.76M | 5.14% | 1,035,611 | 42.17M |
| 283 | EDIT | Editas Medicine, Inc. | 282.85M | -0.69% | 1,769,955 | 40.52M |
| 284 | NERV | Minerva Neurosciences, Inc. | 281.90M | -2.28% | 168,494 | - |
| 285 | ACIU | AC Immune SA | 281.73M | - | 156,478 | 4.51M |
| 286 | NBP | NovaBridge Biosciences | 281.03M | -0.82% | 294,135 | - |
| 287 | CCCC | C4 Therapeutics, Inc. | 276.15M | -1.74% | 1,199,368 | 35.95M |
| 288 | CGEN | Compugen Ltd. | 276.10M | -5.81% | 926,260 | 72.76M |
| 289 | HELP | Cybin Inc. | 270.19M | -3.74% | 1,725,341 | - |
| 290 | TARA | Protara Therapeutics, Inc. | 269.88M | -2.73% | 458,580 | - |
| 291 | ARTV | Artiva Biotherapeutics, Inc. | 265.70M | 4.17% | 133,108 | 251.00K |
| 292 | SGMT | Sagimet Biosciences Inc. | 264.59M | 38.57% | 49,408,802 | - |
| 293 | ELDN | Eledon Pharmaceuticals, Inc. | 262.84M | -0.14% | 1,556,285 | - |
| 294 | ALEC | Alector, Inc. | 259.35M | -2.49% | 592,891 | 21.05M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 251.71M | 2.90% | 20,991 | 19.39M |
| 296 | SABS | SAB Biotherapeutics, Inc. | 243.86M | -1.28% | 423,862 | 114.70K |
| 297 | CDXS | Codexis, Inc. | 240.80M | 1.15% | 1,519,131 | 70.39M |
| 298 | PLYX | Polaryx Therapeutics, Inc. | 240.03M | 4.54% | 83,854 | - |
| 299 | OBIO | Orchestra BioMed Holdings, Inc. | 239.94M | -0.73% | 331,562 | 33.48M |
| 300 | FENC | Fennec Pharmaceuticals Inc. | 236.15M | -0.15% | 125,076 | 44.64M |
| 301 | ARCT | Arcturus Therapeutics Holdings Inc. | 235.91M | -3.38% | 253,766 | 82.03M |
| 302 | ADAG | Adagene Inc. | 235.22M | -3.52% | 92,135 | 7.67M |
| 303 | NVCT | Nuvectis Pharma, Inc. | 231.80M | -1.69% | 35,065 | - |
| 304 | CAMP | Camp4 Therapeutics Corporation | 230.52M | - | 102,504 | 3.50M |
| 305 | MIST | Milestone Pharmaceuticals Inc. | 228.13M | -1.59% | 678,715 | 1.55M |
| 306 | HRTX | Heron Therapeutics, Inc. | 224.48M | - | 3,960,673 | 154.90M |
| 307 | VYGR | Voyager Therapeutics, Inc. | 224.09M | -0.79% | 369,530 | 40.37M |
| 308 | REPL | Replimune Group, Inc. | 221.29M | 10.74% | 5,743,711 | - |
| 309 | KROS | Keros Therapeutics, Inc. | 217.09M | -4.34% | 382,418 | 244.06M |
| 310 | CNTX | Context Therapeutics Inc. | 215.00M | 3.54% | 1,660,567 | - |
| 311 | ALXO | ALX Oncology Holdings Inc. | 213.95M | -4.79% | 1,228,805 | - |
| 312 | MDWD | MediWound Ltd. | 212.96M | -0.90% | 36,380 | 16.96M |
| 313 | ACHV | Achieve Life Sciences, Inc. | 210.83M | -1.49% | 834,788 | - |
| 314 | ENLV | Enlivex Ltd. | 209.44M | -0.70% | 272,922 | - |
| 315 | ELTX | Elicio Therapeutics, Inc. | 208.98M | -2.82% | 262,806 | - |
| 316 | OABI | OmniAb, Inc. | 208.49M | -1.37% | 342,905 | 18.67M |
| 317 | CRBU | Caribou Biosciences, Inc. | 205.84M | - | 2,146,275 | 11.16M |
| 318 | NKTX | Nkarta, Inc. | 201.75M | -3.08% | 1,322,321 | - |
| 319 | OKUR | OnKure Therapeutics, Inc. | 201.57M | 3.96% | 80,603 | - |
| 320 | WHWK | Whitehawk Therapeutics, Inc. | 196.34M | 3.23% | 161,553 | 7.15M |
| 321 | KPTI | Karyopharm Therapeutics Inc. | 195.23M | - | 464,638 | 146.07M |
| 322 | MGNX | MacroGenics, Inc. | 193.86M | -4.39% | 414,475 | 149.50M |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 187.53M | -2.93% | 267,406 | - |
| 324 | RNAC | Cartesian Therapeutics, Inc. | 187.42M | 4.74% | 232,027 | 2.80M |
| 325 | KRRO | Korro Bio, Inc. | 185.19M | -0.39% | 65,946 | 6.39M |
| 326 | UNCY | Unicycive Therapeutics, Inc. | 182.47M | -0.82% | 487,183 | - |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 182.40M | 1.82% | 236,394 | 13.11M |
| 328 | ABOS | Acumen Pharmaceuticals, Inc. | 181.98M | -1.95% | 345,301 | - |
| 329 | DTIL | Precision BioSciences, Inc. | 181.65M | -0.14% | 148,246 | 34.26M |
| 330 | HUMA | Humacyte, Inc. | 178.93M | 15.13% | 8,077,135 | 2.04M |
| 331 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 178.78M | 0.20% | 458,042 | - |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 174.03M | -0.92% | 352,033 | 52.74M |
| 333 | ANTX | AN2 Therapeutics, Inc. | 172.78M | 10.60% | 618,572 | - |
| 334 | BDTX | Black Diamond Therapeutics, Inc. | 167.28M | -1.68% | 686,434 | 70.00M |
| 335 | ORMP | Oramed Pharmaceuticals Inc. | 166.23M | 6.75% | 428,044 | 2.00M |
| 336 | MENS | Jyong Biotech Ltd. | 165.34M | -1.83% | 65,961 | - |
| 337 | TLSA | Tiziana Life Sciences Ltd | 160.81M | -2.33% | 87,595 | - |
| 338 | MOLN | Molecular Partners AG | 159.72M | -2.46% | 1,689 | 856.30K |
| 339 | AGEN | Agenus Inc. | 157.05M | 4.87% | 1,773,678 | 114.20M |
| 340 | PRQR | ProQR Therapeutics N.V. | 156.99M | -3.87% | 1,128,053 | 19.19M |
| 341 | GALT | Galectin Therapeutics Inc. | 156.01M | 1.72% | 180,213 | - |
| 342 | SPRO | Spero Therapeutics, Inc. | 154.57M | -2.55% | 322,733 | 66.80M |
| 343 | SPRB | Spruce Biosciences, Inc. | 154.52M | 5.17% | 109,216 | 697.00K |
| 344 | ALPS | Alps Group Inc | 153.09M | 2.22% | 3,891 | 3.74M |
| 345 | FATE | Fate Therapeutics, Inc. | 152.31M | -1.50% | 1,358,441 | 6.65M |
| 346 | TNYA | Tenaya Therapeutics, Inc. | 151.90M | 4.14% | 3,703,137 | - |
| 347 | ACOG | Alpha Cognition Inc. | 141.31M | -5.39% | 44,848 | 10.22M |
| 348 | HURA | TuHURA Biosciences, Inc. | 141.14M | -5.53% | 931,266 | - |
| 349 | CNTB | Connect Biopharma Holdings Limited | 138.48M | -2.78% | 141,892 | 64.00K |
| 350 | KLRS | Kalaris Therapeutics, Inc. | 138.03M | -1.47% | 17,583 | - |
| 351 | KZIA | Kazia Therapeutics Limited | 136.55M | -2.53% | 242,166 | 1.27M |
| 352 | IMUX | Immunic, Inc. | 130.20M | 13.41% | 409,635 | - |
| 353 | EQ | Equillium, Inc. | 128.98M | -5.56% | 219,308 | 4.39M |
| 354 | IPHA | Innate Pharma S.A. | 127.25M | -0.71% | 9,826 | 10.57M |
| 355 | BMEA | Biomea Fusion, Inc. | 125.08M | -8.47% | 2,461,226 | - |
| 356 | AARD | Aardvark Therapeutics, Inc. | 120.42M | 2.41% | 124,561 | - |
| 357 | VANI | Vivani Medical, Inc. | 117.66M | 2.96% | 447,826 | - |
| 358 | CRDF | Cardiff Oncology, Inc. | 117.59M | - | 423,834 | 593.00K |
| 359 | VRCA | Verrica Pharmaceuticals Inc. | 117.25M | -2.22% | 117,377 | 35.58M |
| 360 | IFRX | InflaRx N.V. | 116.39M | 8.78% | 858,759 | 34.44K |
| 361 | NTHI | NeOnc Technologies Holdings, Inc. | 114.84M | -3.56% | 110,895 | 39.99K |
| 362 | CGTX | Cognition Therapeutics, Inc. | 114.37M | - | 1,075,317 | - |
| 363 | CBUS | Cibus, Inc. | 113.66M | -0.67% | 568,182 | 3.64M |
| 364 | GNLX | Genelux Corporation | 113.59M | 1.59% | 123,298 | 8.00K |
| 365 | ONCY | Oncolytics Biotech Inc. | 112.49M | -5.95% | 6,064,452 | - |
| 366 | KALA | KALA BIO, Inc. | 110.98M | -12.27% | 5,358,763 | - |
| 367 | PEPG | PepGen Inc. | 110.58M | 3.90% | 1,247,597 | - |
| 368 | PYXS | Pyxis Oncology, Inc. | 110.58M | -7.37% | 565,561 | 13.86M |
| 369 | TTRX | Turn Therapeutics Inc. | 110.22M | 4.37% | 12,560 | - |
| 370 | SEER | Seer, Inc. | 110.02M | -1.02% | 362,451 | 16.58M |
| 371 | GUTS | Fractyl Health, Inc. | 103.61M | 5.34% | 2,031,567 | 3.00K |
| 372 | COYA | Coya Therapeutics, Inc. | 103.21M | 1.85% | 140,339 | 7.95M |
| 373 | COEP | Coeptis Therapeutics Holdings, Inc. | 102.06M | 1.17% | 110,988 | 1.36M |
| 374 | NRXP | NRx Pharmaceuticals, Inc. | 100.10M | 3.06% | 1,432,410 | 1.23M |
| 375 | ANIX | Anixa Biosciences, Inc. | 99.58M | -2.62% | 122,754 | - |
| 376 | PMN | ProMIS Neurosciences, Inc. | 99.54M | -1.25% | 45,715 | - |
| 377 | EDSA | Edesa Biotech, Inc. | 99.25M | 53.86% | 9,078,251 | - |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 95.87M | 1.74% | 2,878,056 | 65.34K |
| 379 | ALDX | Aldeyra Therapeutics, Inc. | 95.09M | 1.94% | 1,196,662 | - |
| 380 | NRXS | NeurAxis, Inc. | 93.54M | 3.44% | 164,908 | 3.57M |
| 381 | EXOZ | eXoZymes, Inc. | 89.88M | 1.84% | 1,288 | -700.00 |
| 382 | RANI | Rani Therapeutics Holdings, Inc. | 88.82M | -5.22% | 594,946 | 1.63M |
| 383 | PYPD | PolyPid Ltd. | 87.40M | -0.87% | 34,827 | - |
| 384 | SGMO | Sangamo Therapeutics, Inc. | 87.00M | 10.47% | 11,168,408 | 39.55M |
| 385 | ATHE | Alterity Therapeutics Limited | 86.00M | 4.76% | 54,448 | 4.43M |
| 386 | ACET | Adicet Bio, Inc. | 85.24M | 0.38% | 53,149 | - |
| 387 | CSBR | Champions Oncology, Inc. | 83.60M | 5.37% | 11,905 | 57.95M |
| 388 | PTHS | Pelthos Therapeutics Inc. | 83.12M | 7.42% | 7,819 | 16.80M |
| 389 | OKYO | OKYO Pharma Limited | 82.92M | -1.86% | 52,475 | - |
| 390 | GANX | Gain Therapeutics, Inc. | 82.37M | -1.02% | 495,217 | - |
| 391 | GOSS | Gossamer Bio, Inc. | 81.79M | -3.92% | 6,247,181 | 48.47M |
| 392 | QTTB | Q32 Bio Inc. | 80.02M | -12.06% | 495,172 | 53.74M |
| 393 | TCRX | TScan Therapeutics, Inc. | 78.73M | 3.97% | 936,707 | 10.33M |
| 394 | XBIT | XBiotech Inc. | 78.51M | 2.59% | 33,074 | - |
| 395 | LONA | LeonaBio, Inc. | 78.44M | 0.24% | 14,556 | - |
| 396 | ATYR | aTyr Pharma, Inc. | 77.55M | 0.74% | 1,155,202 | 190.00K |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 76.79M | - | 410,608 | - |
| 398 | FLNA | Filana Therapeutics, Inc. | 75.36M | -3.11% | 280,892 | - |
| 399 | MAIA | MAIA Biotechnology, Inc. | 75.23M | -2.36% | 686,509 | - |
| 400 | IMMP | Immutep Limited | 75.22M | -8.46% | 1,386,639 | 5.28M |
| 401 | PLRX | Pliant Therapeutics, Inc. | 74.92M | -2.42% | 392,411 | - |
| 402 | ICCC | ImmuCell Corporation | 74.73M | -1.20% | 22,639 | 27.64M |
| 403 | OSTX | OS Therapies Incorporated | 74.41M | - | 1,195,249 | - |
| 404 | FBIO | Fortress Biotech, Inc. | 73.10M | -2.58% | 198,879 | 63.26M |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 72.84M | -1.57% | 878,417 | - |
| 406 | ESLA | Estrella Immunopharma, Inc. | 71.68M | 6.33% | 43,532 | - |
| 407 | IBO | Impact BioMedical Inc. | 71.16M | 1.13% | 35,387 | 32.00K |
| 408 | MCRB | Seres Therapeutics, Inc. | 70.17M | -9.63% | 123,175 | 789.00K |
| 409 | ACTU | Actuate Therapeutics, Inc. | 67.58M | -4.04% | 236,494 | - |
| 410 | MNOV | MediciNova, Inc. | 67.43M | - | 45,182 | 409.66K |
| 411 | ANVS | Annovis Bio, Inc. | 65.27M | 8.62% | 1,038,576 | - |
| 412 | IMA | ImageneBio, Inc. | 65.21M | 2.10% | 70,768 | 800.00K |
| 413 | BYSI | BeyondSpring Inc. | 64.15M | -8.50% | 18,363 | 1.88M |
| 414 | IBIO | iBio, Inc. | 61.81M | 1.79% | 955,338 | 300.00K |
| 415 | CING | Cingulate Inc. | 61.17M | -3.84% | 415,440 | - |
| 416 | CUE | Cue Biopharma, Inc. | 58.37M | 1.30% | 945,222 | 27.47M |
| 417 | HYFT | MindWalk Holdings Corp. | 57.61M | -4.92% | 110,843 | 20.70M |
| 418 | MGX | Metagenomi Therapeutics, Inc. | 55.87M | -1.00% | 93,945 | 25.21M |
| 419 | INKT | MiNK Therapeutics, Inc. | 55.32M | 1.74% | 14,095 | - |
| 420 | TIL | Instil Bio, Inc. | 55.14M | 0.87% | 9,230 | - |
| 421 | KZR | Kezar Life Sciences, Inc. | 53.86M | -0.55% | 39,903 | - |
| 422 | ENTX | Entera Bio Ltd. | 53.62M | 2.68% | 128,049 | 42.00K |
| 423 | RADX | Radiopharm Theranostics Limited | 53.51M | 3.10% | 11,593 | 10.86M |
| 424 | PDSB | PDS Biotechnology Corporation | 51.91M | 3.28% | 511,948 | - |
| 425 | HYPD | Hyperion DeFi, Inc. | 50.01M | 5.28% | 721,986 | 813.46K |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 48.82M | 1.43% | 215,168 | - |
| 427 | XLO | Xilio Therapeutics, Inc. | 48.05M | - | 32,352 | 43.77M |
| 428 | NTRB | Nutriband Inc. | 47.29M | -2.65% | 2,627 | 2.28M |
| 429 | ATOS | Atossa Therapeutics, Inc. | 46.93M | -4.39% | 36,629 | - |
| 430 | RLYB | Rallybio Corporation | 46.44M | 1.74% | 95,486 | 858.00K |
| 431 | DWTX | Dogwood Therapeutics, Inc. | 44.76M | -2.90% | 73,773 | - |
| 432 | MREO | Mereo BioPharma Group plc | 44.72M | -3.38% | 1,971,868 | 500.00K |
| 433 | LIXT | Lixte Biotechnology Holdings, Inc. | 44.15M | 2.43% | 17,029 | - |
| 434 | LITS | Lite Strategy, Inc. | 42.54M | -0.85% | 81,432 | - |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 42.27M | -0.79% | 11,934 | - |
| 436 | RNTX | Rein Therapeutics Inc. | 41.78M | -10.24% | 212,447 | - |
| 437 | PSTV | Plus Therapeutics, Inc. | 41.10M | -9.24% | 220,775 | 5.21M |
| 438 | ATRA | Atara Biotherapeutics, Inc. | 40.81M | -0.40% | 52,270 | 120.77M |
| 439 | PTN | Palatin Technologies, Inc. | 40.76M | -3.24% | 6,914 | 8.96M |
| 440 | HOWL | Werewolf Therapeutics, Inc. | 40.34M | 2.09% | 299,127 | 1.14M |
| 441 | ALGS | Aligos Therapeutics, Inc. | 39.79M | 0.47% | 139,730 | 2.19M |
| 442 | RNXT | RenovoRx, Inc. | 39.20M | 1.58% | 243,782 | 1.12M |
| 443 | INMB | INmune Bio Inc. | 39.08M | 5.76% | 225,088 | 50.00K |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 37.72M | -5.47% | 116,797 | 90.00K |
| 445 | VERU | Veru Inc. | 37.56M | 0.86% | 47,665 | 16.89M |
| 446 | SKYE | Skye Bioscience, Inc. | 37.23M | 9.28% | 645,130 | - |
| 447 | CRVO | CervoMed Inc. | 35.37M | -1.55% | 11,986 | 4.01M |
| 448 | EVAX | Evaxion A/S | 34.86M | 3.72% | 37,442 | 7.53M |
| 449 | NXTC | NextCure, Inc. | 34.25M | -8.56% | 31,033 | - |
| 450 | PLUR | Pluri Inc. | 33.87M | 0.75% | 2,624 | 1.34M |
| 451 | GRCE | Grace Therapeutics, Inc. | 33.42M | -6.09% | 1,050,505 | - |
| 452 | SNTI | Senti Biosciences Holdings, Inc. | 33.01M | -2.75% | 142,416 | 22.00K |
| 453 | BOLD | Boundless Bio, Inc. | 32.94M | -2.00% | 62,128 | - |
| 454 | DARE | Daré Bioscience, Inc. | 32.61M | 6.16% | 403,682 | 1.03M |
| 455 | IGC | IGC Pharma, Inc. | 31.63M | -5.04% | 443,075 | 1.11M |
| 456 | DYAI | Dyadic International, Inc. | 29.88M | -4.65% | 33,811 | 3.09M |
| 457 | OTLK | Outlook Therapeutics, Inc. | 29.82M | -9.55% | 3,907,892 | 205.70K |
| 458 | PLRZ | Polyrizon Ltd. | 29.65M | 6.88% | 66,817 | - |
| 459 | BCTX | BriaCell Therapeutics Corp. | 29.18M | 3.87% | 117,019 | - |
| 460 | TVGN | Tevogen Bio Holdings Inc. | 29.15M | -7.28% | 24,654 | - |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 28.61M | -1.61% | 36,980 | - |
| 462 | CELU | Celularity Inc. | 28.55M | -10.81% | 100,467 | 40.58M |
| 463 | KYNB | Kyntra Bio, Inc. | 28.45M | -1.54% | 5,865 | 6.44M |
| 464 | APLM | Apollomics, Inc. | 28.32M | -0.68% | 15,368 | 8.99M |
| 465 | LSTA | Lisata Therapeutics, Inc. | 28.18M | -2.50% | 74,048 | 170.00K |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 27.76M | 2.18% | 48,614 | 14.99M |
| 467 | LTRN | Lantern Pharma Inc. | 27.57M | - | 180,946 | - |
| 468 | NNVC | NanoViricides, Inc. | 26.99M | -0.79% | 326,151 | - |
| 469 | ABVC | ABVC BioPharma, Inc. | 26.69M | 0.93% | 55,574 | 797.92K |
| 470 | NRSN | NeuroSense Therapeutics Ltd. | 26.53M | 0.05% | 67,326 | - |
| 471 | CVM | CEL-SCI Corporation | 26.38M | 1.87% | 85,312 | - |
| 472 | LGVN | Longeveron Inc. | 26.35M | -4.26% | 299,729 | 1.20M |
| 473 | AEON | AEON Biopharma, Inc. | 26.32M | -0.95% | 111,936 | - |
| 474 | JSPR | Jasper Therapeutics, Inc. | 26.03M | 10.91% | 353,967 | - |
| 475 | BRNS | Barinthus Biotherapeutics plc | 25.73M | -1.87% | 13,243 | 14.97M |
| 476 | TPST | Tempest Therapeutics, Inc. | 24.67M | -3.91% | 217,279 | - |
| 477 | MRKR | Marker Therapeutics, Inc. | 24.18M | 3.57% | 90,796 | 3.55M |
| 478 | OSRH | OSR Holdings, Inc. | 23.98M | 4.44% | 2,390,480 | 2.91M |
| 479 | LEXX | Lexaria Bioscience Corp. | 23.56M | 0.69% | 104,770 | 368.00K |
| 480 | CRIS | Curis, Inc. | 23.25M | -2.27% | 186,585 | 9.44M |
| 481 | XCUR | Exicure, Inc. | 22.69M | 2.59% | 9,969 | 500.00K |
| 482 | VTGN | Vistagen Therapeutics, Inc. | 22.64M | -3.81% | 391,501 | 789.00K |
| 483 | SER | Serina Therapeutics, Inc. | 22.17M | -8.63% | 65,006 | 130.00K |
| 484 | ALLR | Allarity Therapeutics, Inc. | 21.67M | 2.24% | 128,882 | 320.00K |
| 485 | VYNE | VYNE Therapeutics Inc. | 21.28M | -1.02% | 26,676 | 570.00K |
| 486 | QNTM | Quantum BioPharma Ltd. | 21.09M | 23.27% | 1,965,706 | - |
| 487 | QNCX | Quince Therapeutics, Inc. | 21.03M | -5.15% | 1,034,203 | - |
| 488 | COCP | Cocrystal Pharma, Inc. | 19.30M | -2.10% | 106,476 | - |
| 489 | LPCN | Lipocine Inc. | 19.02M | -2.07% | 210,822 | 1.98M |
| 490 | PASG | Passage Bio, Inc. | 18.32M | -2.23% | 57,118 | - |
| 491 | NCEL | NewcelX Ltd. | 17.64M | -16.95% | 113,962 | - |
| 492 | CVKD | Cadrenal Therapeutics, Inc. | 17.55M | 3.64% | 46,115 | - |
| 493 | GNTA | Genenta Science S.p.A. | 17.40M | 4.17% | 60,992 | - |
| 494 | KTTA | Pasithea Therapeutics Corp. | 17.21M | - | 217,685 | - |
| 495 | TOVX | Theriva Biologics, Inc. | 16.23M | -7.17% | 6,178,241 | - |
| 496 | PBM | Psyence Biomedical Ltd. | 16.17M | -10.87% | 434,628 | - |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 15.46M | -10.26% | 2,083,269 | 3.94M |
| 498 | INAB | IN8bio, Inc. | 15.36M | 4.00% | 131,082 | - |
| 499 | ICU | SeaStar Medical Holding Corporation | 15.22M | -7.75% | 85,235 | 1.23M |
| 500 | HIND | Vyome Holdings, Inc. | 15.09M | -2.71% | 17,471 | 319.71K |